- Home
- VFL vs RPID Comparison
VFL vs RPID Comparison
Compare VFL & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFL
- RPID
- Stock Information
- Founded
- VFL 1993
- RPID 2006
- Country
- VFL United States
- RPID United States
- Employees
- VFL N/A
- RPID N/A
- Industry
- VFL Finance/Investors Services
- RPID Medical Specialities
- Sector
- VFL Finance
- RPID Health Care
- Exchange
- VFL Nasdaq
- RPID Nasdaq
- Market Cap
- VFL 116.3M
- RPID 106.5M
- IPO Year
- VFL N/A
- RPID 2021
- Fundamental
- Price
- VFL $10.23
- RPID $3.79
- Analyst Decision
- VFL
- RPID Strong Buy
- Analyst Count
- VFL 0
- RPID 2
- Target Price
- VFL N/A
- RPID $8.00
- AVG Volume (30 Days)
- VFL 38.0K
- RPID 71.4K
- Earning Date
- VFL 01-01-0001
- RPID 10-31-2025
- Dividend Yield
- VFL 4.16%
- RPID N/A
- EPS Growth
- VFL N/A
- RPID N/A
- EPS
- VFL N/A
- RPID N/A
- Revenue
- VFL N/A
- RPID $30,289,000.00
- Revenue This Year
- VFL N/A
- RPID $16.63
- Revenue Next Year
- VFL N/A
- RPID $21.98
- P/E Ratio
- VFL N/A
- RPID N/A
- Revenue Growth
- VFL N/A
- RPID 22.57
- 52 Week Low
- VFL $7.93
- RPID $0.83
- 52 Week High
- VFL $10.77
- RPID $4.50
- Technical
- Relative Strength Index (RSI)
- VFL 61.64
- RPID 72.23
- Support Level
- VFL $10.11
- RPID $3.11
- Resistance Level
- VFL $10.34
- RPID $3.38
- Average True Range (ATR)
- VFL 0.09
- RPID 0.25
- MACD
- VFL -0.02
- RPID 0.06
- Stochastic Oscillator
- VFL 38.71
- RPID 95.57
About VFL abrdn National Municipal Income Fund
Delaware Investments Natl Muni Income is a closed-end investment fund. The Fund seeks to provide current income exempt from regular federal income tax consistent with the preservation of capital. The company's product portfolio includes Mutual funds, Exchange-traded funds, Private markets, Delaware Funds by Macquarie Premier Models, Managed accounts, Closed-end funds, and Variable Insurance Products.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.